Qepler | summits & conferences | 2nd Annual Inhaled Drug Delivery Summit | 5-6 August 2021
Event Location:
Online Conference
ZOOM Events
05 - 06 August 2021

Conference Overview

The recent years have witnessed major growth in the inhaled drugs market driven by rising prevalence of chronic pulmonary diseases, the evolution of inhaled therapies and technological advancements in device development. Challenges still remain to ensure safe and efficient respiratory drug delivery - including device and drug integration, particle engineering and formulation technologies, clinical studies and regulatory pathways. Our meeting facilitates hands-on experience sharing of successful development of inhaled drug products for enhanced patient care.

The featured talks on:

  • Understanding of regulations and requirements for OINDPs
  • Aerodynamics and Air Flow Resistance of DPIs
  • Using the inhalation route to delivery drugs to the systemic circulation
  • Lung on chip applications in respiratory health
  • Translating Inhaled and Nasal Technologies for the Delivery of Biologics
  • Inhalation of therapeutics to fight respiratory tract infections
  • Transnasal Pulmonary Drug Delivery in Acute and Critical Care – Practice to Promise
  • The climate is changing for metered dose inhalers
  • Practical challenges with developing inhalation drugs during pre-clinical testing
  • From perception to use - the patient DPI product interface
  • Are sustainability, reusability and carbon neutrality major trends for devices in the future? A case study of Respimat® re-usable
  • The impact of filling technology selection for dry powder formulations on device performance, process consistency and commercial scale-up
  • Postmarket Safety reporting for Combination products in the US
  • ICOpre - Development of a generic DPI platform for a global market

Meet our Speakers

Our Sponsors


3P innovation useful links:


3P innovation, UK - Abdi İbrahim Pharmaceuticals, TR - Accord Healthcare GmbH, DE - Ache Laboratories Pharmaceutics, BR - Aerogen Pharma Corp., USA - AlveoliX AG, CH - Amgen, USA - Arla Foods, UK - Aspen, ZA - Bayer AG, DE - BioCryst, USA - Biovital, DZ - Boehringer Ingelheim microParts GmbH, DE - Boehringer Ingelheim Pharma GmbH & Co. KG, DE - Broughton, UK - Cambridge Design Partnership, UK - CEA , FR - Covance Laboratories, UK - CSL Behring, CH - CSL Behring, DE - DPSRU, IN - Dr. Reddy's Laboratories, IN - E.Z. Solutions Pvt. Ltd. (InveniAI), IN - Evalueserve Pvt Ltd, IN - Explicat Pharma GmbH, DE - Franz Ziel GMBH, DE - Fresenius Kabi Oncology Ltd, IN - GlaxoSmithKline, UK - Glenmark , IN - Graz University of Technology, AT - GSK, UK - Hall Analytical, UK - Hollycon Italy PTE. LTD. Srl, IT - Hovione, PT - i2c Pharmaceutical Services, UK - Iconovo AB, SE - INSERM, FR - Insmed, USA - Inspiring Strategies, UK - Intertek (Schweiz) AG, CH - Intertek Pharmaceutical Services, UK - Iran university of medical sciences, IR - Janssen Pharmaceuticals, USA - Janssen Pharmaceuticals, BE - KIET SCHOOL OF PHARMACY, IN - Kindeva Drug Delivery , UK - Kusum Health Care Pvt. Ltd., IN - OM Pharma Suisse AG, CH - Pharmaceutical Research Center , IN - Pieris Pharmaceuticals GmbH, DE - RAUMEDIC AG, DE - Roskamp Institute, USA - RSSL, UK - Sandoz, USA - Sudair Pharmaceuticals Company, SA - Surface Measurement Systems Ltd., DE - Tavanta Therapeutics Hungary Inc, HU - Teva Branded Pharmaceuticals R&D, USA - Trinity College Dublin, IE - UCB Biopharma SRL, BE - World Health Organization, CH - Xedev, BE - Yuria-Pharm LLC, UA - Zeab Therapeutic Ltd., IN - and others.



3M United Kingdom PLC - 4Pharma - Agartee Technology Inc. - AGES - Medizinmarktaufsicht LCM/QUAL - Aptar Pharma - Aptuit Srl - Boehringer Ingelheim - Boehringer Ingelheim microParts GmbH - Covestro Deutschland AG - CSL Behring - CSL Behring GmbH - Emmace Consulting AB - Ferring Pharmaceuticals - GlaxoSmithKline - Graz University of Technology - Harro Höfliger Verpackungsmaschinen GmbH - Iconovo AB - Inspiring Strategies - JSC «FARMAK» - Nanologica - Novartis - Pari - Paul Johnson Consulting Limited - Saarland University - Skyepharma AG (Vectura Group) - Smithers Rapra Ltd - Softhale NV - Trinity College Dublin - Others